XSHG600530
Market cap423mUSD
Dec 24, Last price
3.99CNY
1D
-1.48%
1Q
54.05%
Jan 2017
-46.80%
Name
Shanghai Jiaoda Onlly Co Ltd
Chart & Performance
Profile
Shanghai Jiaoda Onlly Co., Ltd., together with its subsidiaries, engages in the health-care food business in China. The company offers functional health products, probiotics, traditional tonics, dietary supplements, and natural elements, as well as provides disinfection products. It also engages in the retail and wholesale business of medicines; and food production and sales business. In addition, the company provides road cargo and transportation services, as well as travel agency services. Shanghai Jiaoda Onlly Co., Ltd. was founded in 1990 and is based in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 296,327 -21.43% | 377,150 4.02% | 362,577 8.98% | |||||||
Cost of revenue | 307,639 | 317,929 | 309,425 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (11,312) | 59,222 | 53,151 | |||||||
NOPBT Margin | 15.70% | 14.66% | ||||||||
Operating Taxes | 1,572 | 13,391 | 2,212 | |||||||
Tax Rate | 22.61% | 4.16% | ||||||||
NOPAT | (12,884) | 45,831 | 50,939 | |||||||
Net income | (35,084) | 37,178 -58.48% | ||||||||
Dividends | (5,302) | |||||||||
Dividend yield | 0.28% | |||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 88,700 | 105,801 | 86,952 | |||||||
Long-term debt | 240,456 | 290,725 | 267,167 | |||||||
Deferred revenue | 15,422 | 11,629 | 10,703 | |||||||
Other long-term liabilities | 3,647 | 1 | 1 | |||||||
Net debt | 114,491 | 179,807 | 153,975 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 55,536 | 98,270 | 104,063 | |||||||
CAPEX | (9,553) | |||||||||
Cash from investing activities | (7,950) | 2,344 | ||||||||
Cash from financing activities | (57,538) | |||||||||
FCF | (3,329) | 53,293 | (61,583) | |||||||
Balance | ||||||||||
Cash | 174,512 | 177,667 | 175,573 | |||||||
Long term investments | 40,153 | 39,052 | 24,572 | |||||||
Excess cash | 199,849 | 197,862 | 182,016 | |||||||
Stockholders' equity | 303,205 | 983,796 | 979,422 | |||||||
Invested Capital | 367,328 | 410,658 | 1,004,518 | |||||||
ROIC | 6.48% | 5.34% | ||||||||
ROCE | 9.22% | 4.35% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 701,688 | 774,920 | 774,920 | |||||||
Price | 2.69 -29.21% | 3.80 -13.83% | 4.41 55.83% | |||||||
Market cap | 1,887,540 -35.90% | 2,944,696 -13.83% | 3,417,397 55.83% | |||||||
EV | 2,046,421 | 3,165,745 | 3,609,090 | |||||||
EBITDA | 37,392 | 89,270 | 84,536 | |||||||
EV/EBITDA | 54.73 | 35.46 | 42.69 | |||||||
Interest | 13,556 | 17,319 | 18,224 | |||||||
Interest/NOPBT | 29.24% | 34.29% |